Maintenance Therapy With Fluoxetine in Posttraumatic Stress Disorder: A Placebo-Controlled Discontinuation Study
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The effect of fluoxetine (FLU) in posttraumatic stress disorder was studied in a one-year trial. Subjects received open-label treatment for 6 months, followed by double-blind randomized treatment with FLU or placebo (PBO) for 6 months. Rates of relapse were compared using the Clinical Global Impressions of Improvement. One hundred twenty-three subjects entered open-label treatment, of whom 114 returned at least once. Sixty-two subjects were randomized to receive FLU or PBO, of whom 57 returned at least once and were analyzed. The dose of FLU ranged from 10 to 60 mg/d; at randomization, mean doses were 48.6 and 42.1 mg for FLU and PBO groups. Rates of relapse were 22% for FLU versus 50% for PBO (P = 0.02), and time to relapse on FLU was longer than for PBO (P = 0.02, log-rank statistic). The odds ratio for relapse on PBO relative to FLU was 3.50. No significant differences were found on other measures. Fluoxetine was well tolerated during double-blind treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sheehan, D., Lecrubier, Y., Harnett Sheehan, K., Janavs, J., Weiller, E., Keskiner, A., Schinka, J., Knapp, E., Sheehan, M., & Dunbar, G. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)83297-x · Cited by 2,149
Research works printed but not linked: 10
- Kessler, 1995, Post-traumatic stress disorder in the National Comorbidity Survey., Arch Gen Psychiatry, 1048-, 1060
- Kessler, 2000, Posttraumatic stress disorder: the burden to the individual and society., J Clin Psychiatry, 61, 4
- Brady, 2000, Efficacy and safety of sertraline treatment of post-traumatic stress disorder: a randomized controlled trial., JAMA, 283, 1837, 10.1001/jama.283.14.1837 · DOI · Paper page
- Davidson, 2001, Multi-center double blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder., Arch Gen Psychiatry, 58, 485, 10.1001/archpsyc.58.5.485 · DOI · Paper page
- Davidson, 2001, Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study., Am J Psychiatry, 158, 1974, 10.1176/appi.ajp.158.12.1974 · DOI · Paper page
- Martenyi, 2002, Fluoxetine v placebo in prevention of relapse in post-traumatic stress disorder., Br J Psychiatry, 181, 315, 10.1192/bjp.181.4.315 · DOI · Paper page
- Escalona, 1997, Screening for trauma history on an inpatient affective disorders unit., J Trauma Stress, 10, 299, 10.1002/jts.2490100210 · doi:10.1002/jts.2490100210
- Connor, 2001, The SPRINT: A brief global assessment of PTSD., Int Clin Psychopharmacol, 16, 1, 10.1097/00004850-200109000-00005 · DOI · Paper page
- Davidson, 1997, Assessment of a new self-rating scale for post-traumatic stress disorder., Psychol Med, 27, 153, 10.1017/S0033291796004229 · DOI · Paper page
- Barnett, 2002, Tolerability of fluoxetine in posttraumatic stress disorder., Prog Neuropsychopharmacol Biol Psychiatry, 26, 363, 10.1016/S0278-5846(01)00282-2 · DOI
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
“In RCT discontinuation studies, fluoxetine [1072,1073]”
What Is a “Mood Stabilizer”? An Evidence-Based Response
Bauer, M. S., & Mitchner, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.3 · Cited by 862
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676
“A small number of randomised double-blind placebo-controlled relapse prevention studies find evidence for the efficacy of longer-term treatment, for fluoxetine [I (PCT)] (Martenyi et al., 2002) and sertraline [I (PCT)] (Davidson et al., 2005), but not tiagabine [I (PCT)] (Connor et al., 2006).”
BackgroundBaldwin, D. S., Anderson, I. M., Nutt, D. J., Bandelow, B., Bond, A., Davidson, J. R. T., den Boer, J. A., Fineberg, N. A., Knapp, M., Scott, J., et al. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105059253 · Cited by 617
Self-citation
Metadata
- Authors
- Davidson, J. R. T., Connor, K. M., Hertzberg, M. A., Weisler, R. H., Wilson, W. H., & Payne, V. M.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2005-04
- Volume
- 25
- Issue
- 2
- Pages
- 166-169
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2057881918
- Cited by
- 54
- References
- 1
- FWCI
- 4.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Maintenance Therapy With Fluoxetine in Posttraumatic Stress Disorder: A Placebo-Controlled Discontinuation Study. https://app.cochat.ai/papers/10.1097/01.jcp.0000155817.21467.6c
- The paper
- Davidson, J. R. T., Connor, K. M., Hertzberg, M. A., Weisler, R. H., Wilson, W. H., & Payne, V. M. (2005). Maintenance Therapy With Fluoxetine in Posttraumatic Stress Disorder: A Placebo-Controlled Discontinuation Study. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/01.jcp.0000155817.21467.6c
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.